Lee Ainslie Pulmonx Corp Transaction History

Maverick Capital LTD

  • $5.04 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$29.72 - $45.1 $809,721 - $1.23 Million
-27,245 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$35.98 - $44.48 $271,900 - $336,135
-7,557 Reduced 21.71%
27,245 $980,000
Q2 2021

Aug 16, 2021
BUY
$37.61 - $48.0 $389,376 - $496,944
10,353 Added 42.35%
34,802 $1.54 Million
Q1 2021

May 17, 2021
BUY
$44.0 - $67.54 $1.08 Million - $1.65 Million
24,449 New
24,449 $1.12 Million

Others Institutions Holding LUNG

# of Institutions
124
Shares Held
30.8M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email